CIDRAP newsletters options
In total, 41% of respondents said they had or would vaccinate their children against COVID-19, while 63% and 71% said they would do so against flu and RSV, respectively.
Those who didn't order free tests earlier this fall can request two sets in the latest HHS offer.
A meta-analysis shows a 26% lower risk of heart attacks in people who received a flu vaccine and a 33% reduction in cardiovascular deaths.
The agency says it wants to better understand the risks posed by drug-resistant pathogens in the food and agriculture sector, and what it can do to address them.
The survey revealed their thinking on stewardship barriers and knowledge about legislative efforts on AMR.
New polling data reveals finds some concerns about virus spread over the holidays, but divided view on taking precautions.
The authors noted that misinformation can erode public trust in scientists, which complicates disease-control efforts.
The center also works to address other protein-misfolding disorders such as Alzheimer's and Parkinson's diseases and amyotrophic lateral sclerosis.
Hospitalizations, also on the rise, are highest in seniors and young children.
The authors found no differences among the study participants in time to recovery.
Vaccine effectiveness against hospital admission for the flu was 40%.
The emergency team also treated patients with measles, malnourishment, and malaria.
RSV hospitalizations are now rising in seniors, and only 14.3% have received the new vaccine.
Studies in South Africa and Vietnam also indicate 6 months of treatment with an oral antibiotic could help prevent development of MDR-TB in children and adults.
While most studies have looked at the pandemic’s impact on elementary school kids or teenagers, little attention has been paid to preschool-aged kids.
Low-income countries were hit hardest by coverage gaps and deaths from the virus.
The FDA said the test offers a private and quick testing option, along with streamlined treatment, if needed.
Risk factors for long COVID were Black race, ages 50 to 64, diabetes, and severe infection.
The extra dose reduced risk of infection by 41%, hospitalization or death by 65%.
Health officials are releasing 77,000 more doses, with supply stretched by higher-than-expected demand for the new tool for protecting newborns.
